Results 11 to 20 of about 297,465 (360)
Current Opinion in Gastroenterology, 1999 Carcinoma of the esophagus and gastroesophageal junction continues to be an aggressive cancer with poor prognosis, despite improved surgical results and the potential benefit of combined multimodality regimens. Additional data seem to confirm the rising incidence of adenocarcinoma, although users of nonsteroidal anti-inflammatory drugs seem to have a ...
T, Lerut, G, Decker
openaire +4 more sources
Molecular Oncology, 2023 The identification of the high‐efficiency and non‐invasive biomarkers for hepatocellular carcinoma (HCC) detection is urgently needed. This study aims to screen out potential autoantibodies to tumor‐associated antigens (TAAbs) and to assess their ...
Qian Yang +9 more
doaj +1 more source
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report
Surgical Case Reports, 2020 Background Carcinosarcoma of the esophagus or esophagogastric junction (EGJ) is a rare malignancy with both carcinomatous and sarcomatous components.
Kenichiro Furukawa +4 more
doaj +1 more source
Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran [PDF]
, 2009 We evaluated the effect of NQO1 genetic variation on PAH-DNA adducts in esophageal squamous cell carcinoma (ESCC) in northeast Iran. Golestan Province in northeast of Iran has one of the highest esophageal cancer incidences in the world.
Biramijamal, F. +4 more
core +3 more sources
Surgical Case Reports, 2019 Background Non-occlusive mesenteric ischemia (NOMI) is a rare but life-threatening complication of early postoperative enteral feeding. We herein report two patients who developed NOMI during enteral feeding after esophagectomy. Case presentation In case
Daisuke Kurita +5 more
doaj +1 more source
Nature Communications, 2021 The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve
Shiliang Liu +13 more
doaj +1 more source
Frontiers in Oncology, 2023 BackgroundThe impact of hospital volume on the long-term survival of esophageal squamous cell carcinoma (ESCC) has not been well assessed in China, especially for stage I–III stage ESCC.
Ling-Ling Lei +26 more
doaj +1 more source
Clinical value of predicting bleeding after endoscopic submucosal dissection for early esophageal cancer. [PDF]
World J Gastrointest SurgLiu SN, Chen Z.
europepmc +2 more sources
Esophageal submucosa: The watershed for esophageal cancer [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2011 Submucosal esophageal cancers (pT1b) are considered superficial, implying good survival. However, some are advanced, metastasizing to regional lymph nodes. Interplay of cancer characteristics and lymphatic anatomy may create a watershed, demarcating low-risk from high-risk cancers.
Raja, Siva +6 more
openaire +2 more sources
Surgical Case Reports, 2022 Background Anastomotic stenosis can occur after esophagectomy and gastric tube reconstruction. The effective surgical treatment for refractory anastomotic stenosis, which seems difficult to resolve with endoscopic treatment, has not been established.
Kazuya Yamaguchi +4 more
doaj +1 more source